4507.T Loading...

From GILD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
21:30
Feb 10 ◎
Dietmar Berger Chief Medical Officer, Gilead Sciences, Inc. GILD Q4 FY25 call
Gilead implicitly compares its own twice-yearly HIV candidate (GS3242) against Shionogi's, arguing Shionogi still needs a partner for a complete regimen.
4507.T
HIGH

About 4507.T Analyst Coverage

Buzzberg tracks 4507.T across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Dietmar Berger.